2016 annual financial data
Royalty Pharma 2016 Net margin
Royalty Pharma 2016 net margin with verified reported values.
Direct answer
Net margin was 30.14%.
Operating income was 722,874,000 USD and net income was 565,907,000 USD.
Operating cash flow was -15,581,000 USD.
Get free Royalty Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,877,410,000 USD
- Operating income
- 722,874,000 USD
- Net income
- 565,907,000 USD
- Operating cash flow
- -15,581,000 USD